{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:28:41Z","timestamp":1791264521974,"version":"4.1.0"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.pharmthera.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T21:32:29Z","timestamp":1332883949000},"page":"71-77","source":"Crossref","is-referenced-by-count":57,"title":["Psychotropics in pregnancy: Safety and other considerations"],"prefix":"10.1016","volume":"135","author":[{"given":"Femi","family":"Oyebode","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giles","family":"Berrisford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033291799001270","article-title":"Safety of fluoxetine during the first trimester of pregnancy: A meta-analytical review of epidemiological studies","volume":"30","author":"Addis","year":"2000","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/da.20221","article-title":"Prevalence and correlates of depression in late pregnancy among Nigerian women","volume":"24","author":"Adewuya","year":"2007","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4088\/JCP.v59n0509f","article-title":"Gastroesophageal reflux as a possible result of clozapine treatment","volume":"59","author":"Baker","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0025","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/da.20856","article-title":"The contribution of prenatal and postnatal maternal anxiety and depression to child maladjustment","volume":"28","author":"Barker","year":"2011","journal-title":"Depress Anxiety"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0030","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","article-title":"Paroxetine and congenital malformations: Meta-analysis and consideration of potential confounding factors","volume":"29","author":"Bar-Oz","year":"2007","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0883-9417(98)80004-6","article-title":"The effects of postpartum depression on child development: a meta-analysis","volume":"12","author":"Beck","year":"1998","journal-title":"Arch Psychiatr Nurs"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0040","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.clineuro.2008.05.015","article-title":"Central pontine and extra-pontine myelinolysis: A complication of lithium toxicity in a pregnant woman","volume":"110","author":"Bejot","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0045","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2307\/1130275","article-title":"Maternal depression and motherese: Temporal and intonational features","volume":"59","author":"Bettes","year":"1988","journal-title":"Child Dev"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/FTD.0b013e3181a58fb4","article-title":"Maternal use of venlafaxine near term: Correlation between neonatal effects and plasma concentrations","volume":"31","author":"Boucher","year":"2009","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0055","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2307\/1130516","article-title":"Speech patterning of natural discourse of well and depressed mothers and their young children","volume":"58","author":"Breznitz","year":"1987","journal-title":"Child Dev"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"Casper","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00213-011-2270-z","article-title":"Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: Effects on neonatal adaptation and psychomotor development","volume":"217","author":"Casper","year":"2011","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0075","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.pharmthera.2012.03.008_bb0080","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","article-title":"A reevaluation of risk of in utero exposure to lithium","volume":"271","author":"Cohen","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0090","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","article-title":"Evaluating the postmarketing experience of risperidone use during pregnancy: Pregnancy and neonatal outcomes","volume":"30","author":"Coppola","year":"2007","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0095","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","article-title":"Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy","volume":"16","author":"Davis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.03.008_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/dev.20393","article-title":"Prenatal maternal emotional complaints are associated with cortisol responses in toddler and preschool aged girls","volume":"51","author":"de Bruijn","year":"2009","journal-title":"Dev Psychobiol"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0100","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1471-0528.2008.01752.x","article-title":"The impact of maternal depression in pregnancy on early child development","volume":"115","author":"Deave","year":"2008","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4088\/JCP.v66n0307","article-title":"Safety of haloperidol and penfluridol in pregnancy: A multicenter, prospective, controlled study","volume":"66","author":"Diav-Citrin","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ps.49.8.1081","article-title":"Pregnancy of a patient treated with clozapine","volume":"49","author":"Dickson","year":"1998","journal-title":"Psychiatr Serv"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0115","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4088\/JCP.v67n0817","article-title":"Exposure to mirtazapine during pregnancy: A prospective, comparative study of birth outcomes","volume":"67","author":"Djulus","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.03.008_bb0120","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/adc.2004.064618","article-title":"Prolonged QT interval in an infant of a fluoxetine treated mother","volume":"90","author":"Dubnov","year":"2005","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881107079171","article-title":"Clozapine use in two women with schizophrenia during pregnancy","volume":"22","author":"Duran","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/00048670701732673","article-title":"Antenatal psychosocial risk factors and depression among women living in socioeconomically disadvantaged suburbs in Adelaide, South Australia","volume":"42","author":"Edwards","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/070674370905400405","article-title":"Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large prospective cohort study","volume":"54","author":"Einarson","year":"2009","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/da.20598","article-title":"Adverse effects of antidepressant use in pregnancy: An evaluation of fetal growth and preterm birth","volume":"27","author":"Einarson","year":"2010","journal-title":"Depress Anxiety"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0150","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0155","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.2007.07060879","article-title":"Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy","volume":"165","author":"Einarson","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0135","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00228-008-0609-0","article-title":"Smoking in pregnancy and lactation: A review of risks and cessation strategies","volume":"65","author":"Einarson","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1196\/annals.1376.036","article-title":"Maternal depression and psychotropic medication effects on the human fetus","volume":"1094","author":"Emory","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0165","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.genhosppsych.2007.07.008","article-title":"Antenatal psychiatric morbidity in Maltese women","volume":"29","author":"Felice","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00048674.2010.549995","article-title":"Developmental outcomes of children exposed to antidepressants in pregnancy","volume":"45","author":"Galbally","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.03.008_bb0175","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00048670903107583","article-title":"Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: Prospective controlled study","volume":"43","author":"Galbally","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.03.008_bb0180","first-page":"967","article-title":"Mood stabilizers in pregnancy: A systematic review","volume":"44","author":"Galbally","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00737-009-0080-7","article-title":"Antenatal depression and suicidal ideation among rural Bangladeshi women: A community-based study","volume":"12","author":"Gausia","year":"2009","journal-title":"Arch Womens Ment Health"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2012.03.008_bb0190","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/01.AOG.0000183597.31630.db","article-title":"Perinatal depression: A systematic review of prevalence and incidence","volume":"106","author":"Gavin","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1345\/aph.1D485","article-title":"Clinical utilization of atypical antipsychotics in pregnancy and lactation","volume":"38","author":"Gentile","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.03.008_bb0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1017\/S1092852900014012","article-title":"Pregnancy exposure to serotonin reuptake inhibitors and the risk of spontaneous abortions","volume":"13","author":"Gentile","year":"2008","journal-title":"CNS Spectr"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.03.008_bb0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/da.20706","article-title":"Neurodevelopmental effects of prenatal exposure to psychotropic medications","volume":"27","author":"Gentile","year":"2010","journal-title":"Depress Anxiety"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5249\/jivr.v3i2.98","article-title":"Suicidal mothers","volume":"3","author":"Gentile","year":"2011","journal-title":"J Inj Violence Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0215","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.08r04468","article-title":"Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: Focus on paroxetine","volume":"70","author":"Gentile","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2012.03.008_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.02.125","article-title":"Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review","volume":"128","author":"Gentile","year":"2011","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4088\/JCP.09m05724blu","article-title":"Depression during pregnancy: is the developmental impact earlier in boys? A prospective case\u2013control study","volume":"72","author":"Gerardin","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10995-009-0459-0","article-title":"Prevalence and correlates of depression in pregnancy among Turkish women","volume":"14","author":"Golbasi","year":"2010","journal-title":"Matern Child Health J"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004714-200008000-00002","article-title":"Olanzapine-exposed pregnancies and lactation: Early experience","volume":"20","author":"Goldstein","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00737-003-0024-6","article-title":"The effect of postpartum depression on child cognitive development and behavior: A review and critical analysis of the literature","volume":"6","author":"Grace","year":"2003","journal-title":"Arch Womens Ment Health"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0245","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archgenpsychiatry.2010.111","article-title":"A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction","volume":"67","author":"Grote","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0250","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2431-10-14","article-title":"Maternal postnatal depression and child growth: A European cohort study","volume":"10","author":"Grote","year":"2010","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0954579409000133","article-title":"Trajectories of maternal depressive symptoms over her child's life span: Relation to adrenocortical, cardiovascular, and emotional functioning in children","volume":"21","author":"Gump","year":"2009","journal-title":"Dev Psychopathol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archpsyc.64.1.42","article-title":"Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations","volume":"64","author":"Harlow","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4755-8-9","article-title":"Depressed mood in pregnancy: Prevalence and correlates in two Cape Town peri-urban settlements","volume":"8","author":"Hartley","year":"2011","journal-title":"Reprod Health"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0270","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions: A meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0275","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/j.1447-0756.2010.01512.x","article-title":"Maternal mental disorders and pregnancy outcomes: A clinical study in a Japanese population","volume":"37","author":"Hironaka","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0280","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/GCO.0b013e3282f1bf28","article-title":"Consequences of antenatal mental health problems for child health and development","volume":"19","author":"Hollins","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/appi.ajp.162.1.79","article-title":"Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders","volume":"162","author":"Jablensky","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0290","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ajp.158.6.913","article-title":"Familiality of the puerperal trigger in bipolar disorder: Results of a family study","volume":"158","author":"Jones","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0305","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","article-title":"Neonate characteristics after maternal use of antidepressants in late pregnancy","volume":"158","author":"K\u00e4ll\u00e9n","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0310","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"K\u00e4ll\u00e9n","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Supplement, no. 17","key":"10.1016\/j.pharmthera.2012.03.008_bb0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/S0007125000296918","article-title":"Clinical efficacy of clozapine in treatment-refractory schizophrenia: An overview","author":"Kane","year":"1992","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0295","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0020764008094645","article-title":"Prevalence of anxiety, depression and associated factors among pregnant women of Hyderabad, Pakistan","volume":"55","author":"Karmaliani","year":"2009","journal-title":"Int J Soc Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0315","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"Br Med J"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/GRF.0b013e3181b52df1","article-title":"Impact of maternal stress, depression and anxiety on fetal neurobehavioral development","volume":"52","author":"Kinsella","year":"2009","journal-title":"Clin Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000289062","article-title":"Clinical and psychosocial correlates of antenatal depression: A review","volume":"65","author":"Kitamura","year":"1996","journal-title":"Psychother Psychosom"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0330","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00737-006-0122-3","article-title":"Multicentre prospective study of perinatal depression in Japan: Incidence and correlates of antenatal and postnatal depression","volume":"9","author":"Kitamura","year":"2006","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0340","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.forsciint.2007.04.216","article-title":"Neonatal death following clozapine self-poisoning in late pregnancy: An unusual case report","volume":"171","author":"K\u0142ys","year":"2007","journal-title":"Forensic Sci Int"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0335","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/ajmg.a.30501","article-title":"Neonatal toxicity and transient neurodevelopmental deficits following prenatal exposure to lithium: Another clinical report and a review of the literature","volume":"132","author":"Kozma","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1016\/j.pharmthera.2012.03.008_bb0345","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.socscimed.2007.01.001","article-title":"Correlates of depressive symptomatology during the second trimester of pregnancy among Hong Kong Chinese","volume":"64(","author":"Lau","year":"2007","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0350","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jad.2003.10.003","article-title":"A prevalence study of antenatal depression among Chinese women","volume":"82","author":"Lee","year":"2004","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2012.03.008_bb0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2009.05.019","article-title":"Maternal bipolar disorder increased low birthweight and preterm births: A nationwide population-based study","volume":"121","author":"Lee","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-244X-8-24","article-title":"Risk factors for antenatal depression, postnatal depression and parenting stress","volume":"8","author":"Leigh","year":"2008","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0365","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/00048670903559593","article-title":"Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication","volume":"44","author":"Lewis","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2009.10.011","article-title":"Maternal schizophrenia and pregnancy outcome: does the use of antipsychotics make a difference?","volume":"116","author":"Lin","year":"2010","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0375","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF00918907","article-title":"Maternal depression: Effects on social cognition and behavior in parent\u2013child interactions","volume":"19","author":"Lovejoy","year":"1991","journal-title":"J Abnorm Child Psychol"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.03.008_bb0380","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1089\/jwh.2008.1261","article-title":"Risk factors for major antenatal depression among low-income African American women","volume":"18","author":"Luke","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0385","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpediatrics.2009.164","article-title":"Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes","volume":"163","author":"Lund","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0390","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","article-title":"Neonatal outcome following pregnancy exposure to antidepressants: A prospective controlled cohort study","volume":"115","author":"Maschi","year":"2008","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.pharmthera.2012.03.008_bb0395","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0400","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/appi.neuropsych.19.2.196","article-title":"Possible delayed speech acquisition with clozapine therapy during pregnancy and lactation","volume":"19","author":"Mendhekar","year":"2007","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0405","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/j.midw.2010.10.008","article-title":"Prevalence and factors associated with the development of antenatal and postnatal depression among Jordanian women","volume":"27","author":"Mohammad","year":"2010","journal-title":"Midwifery"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archgenpsychiatry.2008.528","article-title":"Risks and predictors of readmission for a mental disorder during the postpartum period","volume":"66","author":"Munk-Olsen","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0415","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1503\/cmaj.091208","article-title":"Use of antidepressants during pregnancy and the risk of spontaneous abortion","volume":"182","author":"Nakhai-Pour","year":"2010","journal-title":"CMAJ"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.bp.107.041541","article-title":"Birth weight of infants after maternal exposure to typical and atypical antipsychotics: Prospective comparison study","volume":"192","author":"Newham","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.03.008_bb0425","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1176\/appi.ajp.162.11.2162","article-title":"Lithium placental passage and obstetrical outcome: Implications for clinical management during late pregnancy","volume":"162","author":"Newport","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0430","first-page":"119","article-title":"Clozapine and pregnancy","volume":"29","author":"Nguyen","year":"2003","journal-title":"Enc\u00e9phale"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0435","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12325-009-0011-z","article-title":"Teratogenesis associated with antibipolar agents","volume":"26","author":"Nguyen","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0440","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1479-828X.2009.01017.x","article-title":"Atypical antipsychotic (clozapine) self-poisoning in late pregnancy presenting with absent fetal heart rate variability without acidosis and delayed peristalsis in the newborn baby: A case report","volume":"49","author":"Novikova","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.pharmthera.2012.03.008_bb0445","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4002007","article-title":"Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications","volume":"13","author":"Oberlander","year":"2008","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0455","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","article-title":"Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy","volume":"161","author":"Oberlander","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2011.01776.x","article-title":"Reason for clozapine cessation","volume":"125","author":"Pai","year":"2012","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0465","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1177\/070674370204701008","article-title":"Antipsychotic medication during pregnancy and lactation in women with schizophrenia: Evaluating the risk","volume":"47","author":"Patton","year":"2002","journal-title":"Can J Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb0470","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4088\/JCP.v68n0817","article-title":"Birth outcomes following prenatal exposure to antidepressants","volume":"68","author":"Pearson","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0475","doi-asserted-by":"crossref","first-page":"b3569","DOI":"10.1136\/bmj.b3569","article-title":"Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: Population based cohort study","volume":"339","author":"Pedersen","year":"2009","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.03.008_bb0480","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4088\/JCP.10m06090blu","article-title":"Pregnancy as a major determinant for discontinuation of antidepressants: An analysis of data from The Health Improvement Network","volume":"72","author":"Petersen","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0485","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1067\/mob.2002.123610","article-title":"Case report and review of the perinatal implications of maternal lithium use","volume":"187","author":"Pinelli","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0490","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.genhosppsych.2009.02.002","article-title":"Detecting depression during pregnancy and associated lifestyle practices and concerns among women in a hospital-based obstetric clinic in Jamaica","volume":"31","author":"Pottinger","year":"2009","journal-title":"Gen Hosp Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0495","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1192\/bjp.bp.107.042523","article-title":"Duration of antidepressant use during pregnancy and risk of major congenital malformations","volume":"192","author":"Ramos","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0500","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0505","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: An update using Swedish data","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0510","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1017\/S0033291799003025","article-title":"Long-term outcome of severe puerperal psychiatric illness: A 23 year follow-up study","volume":"30","author":"Robling","year":"2000","journal-title":"Psychol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0515","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jad.2011.08.011","article-title":"The prevalence and clinical presentation of antenatal depression in rural South Africa","volume":"135","author":"Rochat","year":"2011","journal-title":"J Affect Disord"},{"issue":"9458","key":"10.1016\/j.pharmthera.2012.03.008_bb0520","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0525","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-244X-11-48","article-title":"Social support and antenatal depression in extended and nuclear family environments in Turkey: A cross-sectional survey","volume":"11","author":"Senturk","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0530","first-page":"242","article-title":"Prevalence of antenatal depression: comparison between Pakistani and Canadian women","volume":"61","author":"Shah","year":"2011","journal-title":"J Pak Med Assoc"},{"issue":"171","key":"10.1016\/j.pharmthera.2012.03.008_bb0535","first-page":"128","article-title":"Depression during pregnancy in a tertiary care center of eastern Nepal","volume":"47","author":"Shakya","year":"2008","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0540","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S1516-44462010000200008","article-title":"Depression during pregnancy in the Brazilian public health care system","volume":"32","author":"Silva","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.03.008_bb0545","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure","volume":"159","author":"Simon","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharmthera.2012.03.008_bb0550","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.158.1.46","article-title":"The relationship between post-natal depression and mother\u2013child interaction","volume":"158","author":"Stein","year":"1991","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0555","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2214.2008.00837.x","article-title":"The influence of maternal depression, caregiving, and socioeconomic status in the post-natal year on children's language development","volume":"34","author":"Stein","year":"2008","journal-title":"Child Care Health Dev"},{"issue":"8","key":"10.1016\/j.pharmthera.2012.03.008_bb5560","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4088\/JCP.v58n0806f","article-title":"Clozapine use in two full-time pregnancies","volume":"58","author":"Stoner","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2012.03.008_bb0560","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4088\/JCP.10m06135","article-title":"A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure","volume":"72","author":"Suri","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"3\u20134","key":"10.1016\/j.pharmthera.2012.03.008_bb0565","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1469-7610.2006.01714.x","article-title":"Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?","volume":"48","author":"Talge","year":"2007","journal-title":"J Child Psychol Psychiatry"},{"issue":"36","key":"10.1016\/j.pharmthera.2012.03.008_bb5570","first-page":"1967","article-title":"Use of clozapine during pregnancy","volume":"135","author":"T\u00e9nyi","year":"1994","journal-title":"Orv Hetil"},{"issue":"10","key":"10.1016\/j.pharmthera.2012.03.008_bb0570","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1345\/aph.1H116","article-title":"Paroxetine use during pregnancy: Is it safe?","volume":"40","author":"Thormahlen","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.pharmthera.2012.03.008_bb0575","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/JCP.0b013e3181bf344c","article-title":"Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction","volume":"29","author":"Toh","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0580","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10673220902899714","article-title":"Infants of depressed mothers","volume":"17","author":"Tronick","year":"2009","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0585","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.157.2.179","article-title":"Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance","volume":"157","author":"Viguera","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmthera.2012.03.008_bb0590","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1176\/appi.ajp.2007.06101639","article-title":"Risk of recurrence in women with bipolar disorder during pregnancy: Prospective study of mood stabilizer discontinuation","volume":"164(","author":"Viguera","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0595","first-page":"CD004411","article-title":"Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum","author":"Webb","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.03.008_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00737-008-0044-3","article-title":"Atypical antipsychotic use in pregnancy: A retrospective review","volume":"12","author":"Wichman","year":"2009","journal-title":"Arch Womens Ment Health"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.03.008_bb0605","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":"Major depression and antidepressant treatment: Impact on pregnancy and neonatal outcomes","volume":"166","author":"Wisner","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0610","first-page":"95","article-title":"Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review","volume":"45","author":"Yacobi","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"2","key":"10.1016\/j.pharmthera.2012.03.008_bb0615","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.reprotox.2004.07.004","article-title":"Newer antidepressants in pregnancy: Prospective outcome of a case series","volume":"19","author":"Yaris","year":"2004","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0620","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0020-7292(02)00276-X","article-title":"Maternal clozapine treatment and decreased fetal heart rate variability","volume":"79","author":"Yogev","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.pharmthera.2012.03.008_bb0625","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00916455","article-title":"The effects of maternal mood on mother\u2013infant interaction","volume":"15","author":"Zekoski","year":"1987","journal-title":"J Abnorm Child Psychol"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:48:12Z","timestamp":1561510092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0163725812000642"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.03.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}